Generic Name: Arterolane and Piperaquine
SYNRIAM is a medication primarily used for the treatment of uncomplicated Plasmodium falciparum malaria.
Usually taken orally, this combination medication is typically prescribed in a specific dosage regimen by healthcare professionals.
Proper use and compliance with the prescribed dosage are essential to ensure the medication's effectiveness and minimize the risk of drug resistance.
SYNRIAM Tablet is an important tool in the fight against malaria, particularly in regions where drug-resistant malaria is a concern, as it combines two active ingredients to improve the efficacy of treatment.

• Customer-Centric Solutions: Parshva Agency focuses on delivering tailored private labeling services on a Peer-to-Peer (P2P) basis to meet the unique needs of each client.
• Regulatory Support: The agency is backed by experienced regulatory experts who ensure full compliance with all industry standards, providing peace of mind to clients.
• State-of-the-Art Manufacturing: Partnered with advanced manufacturing facilities that meet WHO-GMP certifications, Parshva Agency emphasizes the importance of modern production techniques.
• Quality and Efficacy: With WHO-GMP certification, the agency guarantees that its products maintain the highest standards of quality and efficacy.
• Reliability: Parshva Agency is committed to providing safe, reliable, and compliant products that meet stringent regulatory guidelines, fostering trust among clients and stakeholders.